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Abstract 
Background: Urinary tract infection is one of the major public health problems. Specific population studies to 
understand the common etiologic agents and antibiotic susceptibility patterns are important to determine the 
empirical treatment of urinary tract infections. This is the first study in Bhutan to analyze the etiologic agents and anti-
biotic susceptibility pattern of uropathogens isolated from patients visiting Jigme Dorji Wangchuck National Referral 
Hospital with the ultimate goal of guiding empirical treatment.
Methods: Hospital based (inpatients/outpatients) retrospective cross sectional study of 6030 clinically suspected 
patients with urinary tract infections who have submitted urine samples for culture in a 6 months period was done. 
Urine samples were collected and processed as per standard microbiological procedures and antibiotic susceptibility 
testing performed by CLSI guidelines.
Results: Significant bacteriuria were detected in 14.9 % of the total patients. The most common uropathogens 
isolated were Escherichia coli (79.3 %) followed by Klebsiella pneumoniae. Females around the age group of 18–26 
have the highest prevalence of urinary tract infection. The highest rate of antibiotic resistance was seen in amoxicillin 
(71.4 %) and nalidixic acid (80.3 %), and resistance were lower in nitrofuration (3.4 %) and gentamycin (17.5 %). The 
third generation cephalosporin resistance (which is a surrogate marker of ESBL) was 16.1 % in outpatient and 16.7 % 
approximately in inpatient setting.
Conclusion: Escherichia coli was the predominant uropathogen making up 79.3 % (outpatient 81.1 % and inpatient 
69.5 %) of the total and its antibiotic susceptibility pattern needs to be considered for treating community-acquired 
UTIs empirically. The third generation cephalosporin resistance (which is a surrogate marker of ESBL) is alarmingly 
high among the isolates and there is need for further studies.
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Background
Urinary tract infection is considered to be a major public 
health problem worldwide with an estimate of 150 million 
cases recorded per year [1]. The management of UTI has 
been profoundly easy with the introduction of antimicro-
bial susceptibility testing [2]: however antimicrobial resist-
ance is a growing problem and is a major concern in many 
countries [3]. There is no study on this subject in Bhutan 
till date. Many studies have proven Escherichia coli to be 
the commonest causative agent of UTI [3–6]. However 
other agents like other enteriobacteriaciae, Acinetobacter 
spp. and Gram positive organism such as Staphylococcus 
saprophyticus, other Staphylococcus aureus and Enterococ-
cus spp. are also commonly involved [3, 4, 6].
The resistance to many of the commonly prescribed 
antibiotics for UTI like amoxicillin, co-trimoxazole and 
norfloxacin has emerged over the past decade [7–10]. In 
our laboratory too, we see lot of resistant bacteria in our 
daily work but this has never been formally studied. Since 
most of the UTI are treated empirically, the selection of 
the antimicrobials agents should be determined by the 
most likely pathogen and its resistance pattern in a par-
ticular community [11–13]. Therefore the best choice of 
empirical treatment should be determined and there is 
a need of periodic monitoring of etiologic agents of UTI 
and their resistance pattern [12, 13].
Methods
Study design
This was a retrospective analysis study. The study was 
carried out in the microbiology unit of the Department 
of Laboratory Services, Jigme Dorji Wangchuck National 
Referral Hospital. The 350 bedded hospital, caters to 
patients from all over the country being the country’s 
national referral hospital.
Study population and study duration
The study was a retrospective review of the urine cultures 
done in the microbiology unit of the Department of Lab-
oratory Services for 6 months from January to June 2013. 
It included all urine samples received during the defined 
period from all types of patients. It involved only review 
of the sample processing registers for that period. From 
the register inpatient and outpatient samples were identi-
fied. Though it was very difficult to completely ascertain 
that all inpatient samples are hospital acquired UTI, for 
the estimate of UTI acquired in community and hospital, 
all the outpatient samples have been treated as commu-
nity acquired-UTI. In addition since the register doesn’t 
have the details of clinical syndrome we assume that all 
the outpatient samples are from simple/uncomplicated 
symptomatic cystitis as without the symptoms patients 
are not sent for urine culture.
Bacterial isolates were identified by routine procedures 
in the laboratory and the antibiotic susceptibility testing 
was done by the CLSI method [2].
Data collection
No patient details that may link to the patient identity like 
names was used and the confidentially was maintained. 
Data was collected from the register which included only 
demographic features like age, sex, location (outpatient 
or inpatient) and antibiotic susceptibility results.
Data analysis
Data were entered and analyzed using SPSS version 14. 
Discrete variables were expressed as percentages and 
proportions were compared using the Chi square (χ2) 
test. Statistical difference were considered significant at p 
value of <0.05.
Ethical clearance
Permission for waiver of ethical clearance was provided 
by Research Ethics Board of Health (REBH), Ministry of 
Health, Bhutan, since this is just a retrospective analy-
sis of the urine culture results from patient registers. No 
patient details were used for analysis.
Sample processing
Antibiotic susceptibility testing was performed for the iso-
lates as per the CLSI guidelines [2]. The primary isolates 
were inoculated into Mueller–Hinton agar plates with 
antibiotic disks and incubated for 18–24  h at 37  °C. The 
following antibiotic disks were used: amoxicillin 10  mcg, 
cefotaxime 30  mcg, ceftriaxone 30  mcg, gentamicin 
10 mcg, nitrofurantoin 300 mcg, cefazolin 30 mcg, ceftri-
axone 30 mcg, nalidixic acid 30 mcg, norfloxacin 10 mcg, 
co-trimoxazole 25 mcg, gentamicin 10 mcg, nitrofurantoin 
300 mcg, cefoxitin 30 mcg, vancomycin 30 mcg, penicillin 
G 10units, erythromycin 15 mcg. The results break points 
were interpreted according to Clinical and Laboratory 
Standards Institute guidelines [2]. ATCC strains for quality 
control used are E. coli ATCC 25922, Pseudomonas aerugi-
nosa ATCC 27853 for Gram negatives and S. aureus ATCC 
25923 for Gram positive isolates.
Limitations
1. Because of the limited patient details entered in the 
register it was impossible to provide clinical and pre-
vious therapeutic details including the catheterized 
patients.
2. Though the register indicates inpatients and outpa-
tients, ascertaining definite hospital acquired UTI 
among inpatients was difficult.
3. Though CLSI method was established and practiced 
for all microbiological processing, there may have 
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been some discrepancies depending on the sample 
collection and processing performed by different staff 
on duties at different times.
Results
A total of 6030 urine samples from clinically suspected 
patients were tested and analyzed for the study compris-
ing of 1156 male and 4874 female patients over a period 
of 6 months. The age range of the patients was between 
18 days and 87 years with a median of 40.1. A total of 863 
(14.3 %) samples were culture positive showing significant 
bacteriuria and the remaining 5167 (85.6  %) were either 
insignificant or with sterile urine. Outpatient had a preva-
lence of 14.8 % and inpatient had 12.1 % respectively.
Out of 6030 patients in total, 4874 (80.8 %) were female 
and among these 729 (14.9 %) showed culture positive sig-
nificant bacteriuria. From 1156 male patients, only 125 
(10.8 %) had UTI. Female gender was a significant risk fac-
tor for acquiring UTI (OR 1.44, 95 % CI 1.17–1.76, and sta-
tistically significant p value of <0.001. The incidence was 
found to be more in female especially in the age group of 
18–26 than the other counter parts of all age groups.
From a total of 863 isolates E. coli alone accounted 685 
(79.3 %), other Gram negative isolates 104 (12 %), Gram 
positives 53 (6.1 %) and 9 (1 %) Candida spp. E. coli were 
the most pre-dominant isolate with the frequency of 
81.1 % among the outpatient and 69.5 % in outpatient set-
ting, causing UTI followed by K. pneumoniae 36 (4.1 %). 
Table 1 illustrates the overall frequency of uropathogens 
isolated.
A total of 12 different antimicrobials were tested 
against all uropathogens, among which nitrofuran-
toin, gentamicin, ceftriaxone and cefotaxime were most 
effective than other antimicrobials such as: amoxycillin, 
nalidixic acid and co-trimoxazole. The percentage of anti-
microbial resistance of the different uropathogen isolates 
to a panel of antimicrobials routinely used is summarized 
in Table 2. Overall Gram negative isolates showed higher 
resistant pattern in comparison with Gram positive iso-
lates. Escherichia coli being the predominant cause of 
UTI infection showed highest resistance to commonly 
used antimicrobials: nalidixic acid (Out 74.9, In 85.1) fol-
lowed by amoxycillin (Out 67.1, In 75.8) and co-trimox-
azole (Out 54.2, In 62.6). Least resistance was seen in 
nitrofurantoin (Out 2.6, In 4.3), followed by gentamicin 
(Out 15.4, In 19.7). Figure 1 illustrates.
Other Gram Negative organisms isolated (data not 
shown as a figure) were least resistant to gentamycin 
(Out 13.4, In 50) followed by norfloxacin (Out 21.4, In 
24.9) and cefotaxime (Out 19.8, In 37). Pseudomonas 
spp. was excluded from the data analysis in this study 
since there was only 1.4  % incidence and it is usually 
considered to be nosocomial infections. Gram positives 
on the other hand were sensitive to most of the antimi-
crobials with 100 % sensitive to vancomycin followed by 
nitrofurantoin (95.1 %) respectively. The resistance rates 
for third generation cephalosporin (which is a surrogate 
marker of ESBL) is striking (CRO 15.8 %, CTX 15.9 %). 
Since there is no particular method used to define ESBL 
in this study there is a need for further studies required.
Discussion
Urinary tract infection is one of the most common and 
serious infectious disease which affects all age groups of 
people including men, women and children worldwide 
[1, 11]. Empirical treatment should be based on local data 
regarding common uropathogens and their antimicro-
bial susceptibility to available antibiotics [11, 12]. This is 
the first study conducted to determine the prevalence of 
UTI, the effect of gender and age on its frequency and the 
susceptibility profile of uropathogens isolated in patients 
visiting JDW/National Referral Hospital. This study pro-
vides valuable laboratory data to monitor the status of 
antimicrobial resistance among uropathogens and to 
improve empirical treatment recommendations in a spe-
cific region.
In this study a total of 6030 patient’s urine samples were 
analyzed, only 14.1 % had a bacterial UTI and 0.14 % had 
Candida spp. infection. This finding has been similar in 
line with studies done in Iran by Farajnia et al. [4] which 
have an isolation rate of 13.2  %. However the isolation 
rate of bacteria from urine is comparatively lower than the 
reports from other parts of the world [3, 14]. This might 
have been due to limited documentation of clinical syn-
drome, previous therapeutic details and sample provision 
Table 1 Frequency of uropathogen isolates
Isolates Outpatient Inpatient Overall prevalence 
(no, %)
No % No %
E. coli 594 81.1 91 69.5 685 (79.23)
K. pneumonia 30 4.1 6 4.6 36 (4.1)
Enterococcus spp. 14 1.9 9 6.9 23 (2.6)
S. saprophyticus 16 2.1 4 3.1 20 (2.3)
Acinetobacter spp. 14 1.9 4 3.1 18 (2.08)
P. mirabilis 12 1.6 2 1.5 14 (1.6)
Pseudomonas spp. 9 1.2 3 2.3 12 (1.4)
K. oxytoca 7 0.9 3 2.3 10 (1.1)
Citrobacter 8 1.1 1 0.8 9 (1)
P. vulgaris 7 0.9 2 1.5 9 (1)
S. aureus 6 0.8 1 0.8 7 (0.8)
Enterobacter spp. 7 0.9 1 0.8 8 (0.9)
Streptococcus spp. 2 0.3 1 0.8 3 (0.3)
Candida spp. 6 0.2 3 2.3 9 (1)
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as ascertaining definite hospital acquired UTI was diffi-
cult. Free primary medical service provided in the coun-
try and irrational use of laboratory service or the studies 
might have been based on the retrospective surveillance. 
The other factors includes the discrepancies depending on 
the sample collection and processing performed by differ-
ent staff on duties at different time despite the establish-
ment of CLSI method in the microbiology lab.
The incidence of infection was higher among females 
of sub group 18–26  years in the current study. Similar 
reports were observed by Dash et  al. [3] in India and 
Akoachere et al. in Cameroonian town [14]. In our pre-
sent study E. coli accounted 79.3 % followed by K. pneu-
moniae 4.1  % to be the main etiologic agent causing 
urinary tract infection. Escherichia coli being the pre-
dominated cause, this correlates exactly with the other 
studies conducted by Schmiemann et al. in Germany [15] 
which also accounted E. coli to be the causative agent 
with 79 % prevalence. Similar studies conducted in devel-
oping countries [5, 7, 9, 14], proved E. coli to be the caus-
ative agent followed by K. pneumoniae.
Most of the international guidelines for treatment of 
community acquired urinary tract infection suggest co-
trimoxazole, amoxycillin/ampicillin, norfloxacin as a pre-
ferred empirical treatment [11]. However the guidelines 
have a suggestion that local antimicrobial susceptibility 
pattern must be taken in account before choosing any 
antibiotics [12]. And also the rate of >20  % resistance 
in the community is the most accepted rate for empiric 
decisions as suggested by the infectious diseases society 
of America. All the studies conducted in various part of 
the world have proved the resistance of uropathogens 
to commonly prescribed antimicrobial agents such as 
amoxycillin/ampicillin and co-trimoxazole [3, 6, 7, 9–
11, 13–16]. The present study also supports that resist-
ance to these antimicrobials have been evolved with the 
resistance rate of 80.3, 71.4 and 58.4  % respectively for 
nalidixic acid, amoxycillin and co-trimoxazole. This pre-
liminary finding of high resistance rate for the commonly 
used antibiotics has a huge public health implications. 
Currently health care is free in the country including 
consultations, laboratory investigations and treatment. 
This high resistance might warrant the change of empiri-
cal antibiotic treatment of UTI in the country resulting 
into the change of the national essential drug list and 
existing guidelines. In addition this high resistance rate is 
surprising in the country where over the counter antibi-
otics prescribing is almost non-existed.
Conclusion
This study findings showed that E. coli was the pre domi-
nant uropathogen with overall 79.3  % (outpatient 81.1, 
inpatient 69.5) prevalence and its antibiotic susceptibil-
ity should be considered for treating community acquired 
urinary tract infection empirically. Since the rate of >20 % 
resistance in the community is the most accepted rate for 
empiric decision as suggested by infectious diseases soci-
ety of America(IDSA), nitrofurantoin remains the choice 
for treatment of community acquired urinary tract infec-
tion empirically. The antibiotic resistance among the 
uropathogens is an evolving process so a routine sur-
veillance to monitor the etiologic agents of UTI and the 
resistance pattern should be carried out timely to choose 
the most effective empirical treatment by the physicians. 
Fig. 1 Antibiogram of E. coli
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The third generation cephalosporin resistance (which is a 
surrogate marker of ESBL) was 16.1 % in outpatient and 
16.7 % approximately in inpatient setting which is alarm-
ingly high and there is need for further studies.
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